Journal of thrombosis and thrombolysis, , Muntner, Paul; Becker, Richard C; Calhoun, David; Chen, Daian; Cowley, Allen W; Flynn, Joseph T; Grobe, Justin L; Kidambi, Srividya; Kotchen, Theodore A; Lackland, Daniel T; Leslie, Kimberly K; Li, Yingchuan; Liang, Mingyu; Lloyd, Augusta; Mattson, David L; Mendizabal, Brenda; Mitsnefes, Mark; Nair, Anand; Pierce, Gary L; Pollock, Jennifer S; Safford, Monika M; Santillan, Mark K; Sigmund, Curt D; Thomas, Stephen J; Urbina, Elaine M 2016. Gastrointestinal Bleeding in Patients WithAtrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. Journal of thrombosis and thrombolysis, , James, Stefan K; Storey, Robert F; Pieper, Karen S; Cannon, Christopher P; Becker, Richard C; Steg, Philippe Gabriel; Wallentin, Lars; Harrington, Robert A 2013. Quality of care & clinical outcomes, 5 2, 145-152, Gouin, Todd; Becker, Richard A; Collot, Anne-Gaelle; Davis, John W; Howard, Brett; Inawaka, Kunifumi; Lampi, Mark; Ramon, Blanca Serrano; Shi, Jay; Hopp, Philipp W 2019. Hypertension (Dallas, Tex. Dr. Kevin Becker, MD, is a Neurology specialist practicing in New Haven, CT with 18 years of experience. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. You lie on a table where a device delivers the radiation for five to 10 minutes. Report of an ISRTP Workshop: Progress and barriers to incorporating alternative toxicological methods in the U.S. Richard A. Becker, Christopher J. Borgert, Simon Webb, Jay Ansell, Sara Amundson, Christopher J. Portier, Alan M. Goldberg, L.H. 2000 -2011. Instruments for assessing risk of bias and other methodological criteria of animal studies: omission of well-established methods. Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial). Journal of thrombosis and thrombolysis, 52 4, 983-984, Becker, Richard C; Sexton, Travis; Smyth, Susan 2021. Geophysical research letters, 40 23, 6033-6037, Xu, Weixian; Holmes, Dajuanicia N; Becker, Richard C; Roe, Matthew T; Peterson, Eric D; Wang, Tracy Y 2013. Nature reviews. Drug discovery today, , Steinberg, Benjamin A; Hellkamp, Anne S; Lokhnygina, Yuliya; Halperin, Jonathan L; Breithardt, Gnter; Passman, Rod; Hankey, Graeme J; Patel, Manesh R; Becker, Richard C; Singer, Daniel E; Hacke, Werner; Berkowitz, Scott D; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M; Piccini, Jonathan P 2014. Building scientific confidence in the development and evaluation of read-across. Journal of thrombosis and thrombolysis, 35 1, 48-56, Mahaffey, Kenneth W; Wojdyla, Daniel; Hankey, Graeme J; White, Harvey D; Nessel, Christopher C; Piccini, Jonathan P; Patel, Manesh R; Berkowitz, Scott D; Becker, Richard C; Halperin, Jonathan L; Singer, Daniel E; Califf, Robert M; Fox, Keith A A; Breithardt, Gnter; Hacke, Werner 2013. Ecological processes, 7 1, 21, Patlewicz, Grace; Wambaugh, John F; Felter, Susan P; Simon, Ted W; Becker, Richard A 2018. He has 38-plus years of experience. screening is at least $3 billion, with much of it paid for by Medicare and the Veterans Administration. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. Nancy B. Beck, Richard A. Becker, Neeraja K. Erraguntla, William H. Farland, Roberta L. Grant, George M. Gray, Christopher R. Kirman, Judy S. LaKind, R. Jeffrey Lewis, Patricia Nance, Lynn H. Pottenger, Susan L. Santos, Stephanie Shirley, Ted W. Simon, Michael L. Dourson. Circulation, 105 18, e159-64, Dyke, Christopher K; Becker, Richard C; Kleiman, Neal S; Hochman, Judith S; Bovill, Edwin G; Lincoff, A Michael; Gerstenblith, Gary; Dzavik, Vladimir; Gardner, Laura H; Hasselblad, Vic; Zillman, Linda A; Shimoto, Yoshimasa; Robertson, Thomas L; Kunitada, Satoshi; Armstrong, Paul W; Harrington, Robert A 2002. Journal of thrombosis and thrombolysis, 32 1, 125-8, Faxon, David P; Eikelboom, John W; Berger, Peter B; Holmes, David R; Bhatt, Deepak L; Moliterno, David J; Becker, Richard C; Angiolillo, Dominick J 2011. Regulatory toxicology and pharmacology : RTP, 90 , 185-196, Becker, Richard C 2017. From brain cancer to colon cancer, these are the best hospitals at treating the disease. Thrombosis research, 156 , 184-190, Washam, Jeffrey B; Hellkamp, Anne S; Lokhnygina, Yuliya; Piccini, Jonathan P; Berkowitz, Scott D; Nessel, Christopher C; Becker, Richard C; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Singer, Daniel E; Patel, Manesh R 2017. Circulation, 120 24, 2488-95, Smyth, S S; McEver, R P; Weyrich, A S; Morrell, C N; Hoffman, M R; Arepally, G M; French, P A; Dauerman, H L; Becker, R C 2009. Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy. Your Health With Dr. Richard and Cindy Becker. Welsby, Ian J; Phillips-Bute, Barbara; Mathew, Joseph P; Newman, Mark F; Becker, Richard; Rao, Sunil; Milano, Carmelo A; Stafford-Smith, Mark 2014. Funding opportunities for clinical investigators in the early stages of career development in cardiovascular research. Tiered toxicity testing: evaluation of toxicity-based decision triggers for human health hazard characterization. Reports have shown that -glucans exert multiple effects on cancer cells and cancer prevention. The New England journal of medicine, 382 20, 1883-1893, Beames, Tyler; Moreau, Marjory; Roberts, L Avery; Mansouri, Kamel; Haider, Saad; Smeltz, Marci; Nicolas, Chantel I; Doheny, Daniel; Phillips, Martin B; Yoon, Miyoung; Becker, Richard A; McMullen, Patrick D; Andersen, Melvin E; Clewell, Rebecca A; Hartman, Jessica K 2020. View the PDF. 231 Albert Sabin Way, ML 0542 Wallentin, Lars; Becker, Richard C; Cannon, Christopher P; Held, Claes; Himmelmann, Anders; Husted, Steen; James, Stefan K; Katus, Hugo A; Mahaffey, Kenneth M; Pieper, Karen S; Storey, Robert F; Steg, Philippe Gabriel; Harrington, Robert A 2014. Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial. Hospitals & health networks / AHA, 76 7, 30, Bonow, Robert O; Mitch, William E; Nesto, Richard W; O'Gara, Patrick T; Becker, Richard C; Clark, Luther T; Hunt, Sharon; Jialal, Ishwarlal; Lipshultz, Stephen E; Loh, Evan 2002. said Dr. Richard Hoffman, . Circulation, 114 23, 2490-7, Patel, Manesh R; Meine, Trip J; Lindblad, Lauren; Griffin, Jeffrey; Granger, Christopher B; Becker, Richard C; Van de Werf, Frans; White, Harvey; Califf, Robert M; Harrington, Robert A 2006. Utilizing Threshold of Toxicological Concern (TTC) with High Throughput Exposure Predictions (HTE) as a Risk-Based Prioritization Approach for thousands of chemicals. Stott. Relevance weighting of tier 1 endocrine screening endpoints by rank order. Journal of thrombosis and thrombolysis, 48 1, 14-26, Nimjee, Shahid M; Dornbos, David; Pitoc, George A; Wheeler, Debra G; Layzer, Juliana M; Venetos, Nicholas; Huttinger, Allyson; Talentino, Spencer E; Musgrave, Nicholas J; Moody, Holly; Rempel, Rachel E; Jones, Cheyenne; Carlisle, Kendyl; Wilson, Jenna; Bratton, Camille; Joseph, Matthew E; Khan, Shoeb; Hoffman, Maureane R; Sommerville, Laura; Becker, Richard C; Zweier, Jay L; Sullenger, Bruce A 2019. Bernacki, Gwen M; Becker, Richard C 2013. The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Platelet P2Y12 receptor antagonist pharmacokinetics and pharmacodynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapies. The American journal of gastroenterology, 104 12, 2903-17, Berger, Jeffrey S; Elliott, Laine; Gallup, Dianne; Roe, Matthew; Granger, Christopher B; Armstrong, Paul W; Simes, R John; White, Harvey D; Van de Werf, Frans; Topol, Eric J; Hochman, Judith S; Newby, L Kristin; Harrington, Robert A; Califf, Robert M; Becker, Richard C; Douglas, Pamela S 2009. academyimpossible twitch bot. Journal of thrombosis and thrombolysis, 37 3, 362-71, Storey, Robert F; Kotha, Jayaprakash; Smyth, Susan S; Moliterno, David J; Rorick, Tyrus L; Moccetti, Tiziano; Valgimigli, Marco; Dery, Jean Pierre; Cornel, Jan H; Thomas, Gregory S; Huber, Kurt; Harrington, Robert A; Hord, Edward; Judge, Heather M; Chen, Edmond; Strony, John; Mahaffey, Kenneth W; Tricoci, Pierluigi; Becker, Richard C; Jennings, Lisa K 2014. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. Framework for use of toxicity screening tools in context-based decision-making. European heart journal, 36 29, 1901-12, Velders, Matthijs A; Wallentin, Lars; Becker, Richard C; van Boven, Adrianus J; Himmelmann, Anders; Husted, Steen; Katus, Hugo A; Lindholm, Daniel; Morais, Joao; Siegbahn, Agneta; Storey, Robert F; Wernroth, Lisa; James, Stefan K 2015. Clasen, R. A., Hartmann, J. F., Coogan, P. S., Pandolfi, S., Laing, I., Becker, R. A. University of Cincinnati Department of Internal Medicine Division of Cardiovascular Health and Diseases 231 Albert Sabin Way, ML 0542 Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitor. Let us know if this information is out of date or incorrect. The New England journal of medicine, 358 26, 2827-9, Becker, Richard C 2007. Circulation, 134 1, 37-47, Johansson, sa; Eriksson, Niclas; Lindholm, Daniel; Varenhorst, Christoph; James, Stefan; Syvnen, Ann-Christine; Axelsson, Tomas; Siegbahn, Agneta; Barratt, Bryan J; Becker, Richard C; Himmelmann, Anders; Katus, Hugo A; Steg, Philippe Gabriel; Storey, Robert F; Wallentin, Lars 2016. Rusyn, Ivan; Sakolish, Courtney; Kato, Yuki; Stephan, Clifford; Vergara, Leoncio; Hewitt, Philip; Bhaskaran, Vasanthi; Davis, Myrtle; Hardwick, Rhiannon; Ferguson, Stephen S; Stanko, Jason P; Bajaj, Piyush; Adkins, Karissa; Sipes, Nisha S; Hunter, Sid; Baltazar, Maria T; Carmichael, Paul L; Sadh, Kritika; Becker, Richard A 2022. Journal of thrombosis and thrombolysis, 50 1, 33-42, Becker, Richard C 2020. ABO blood group influences transfusion and survival after cardiac surgery. Cardiology and the critical care crisis: a perspective. Research focuses on platelets, coagulation proteins, nucleic acids, cell-free DNA-histone complexes and oligonucleotides as reversibleantithrombotic agents. Journal of thrombosis and thrombolysis, 49 2, 177-183, Becker, Richard C; Phillip Owens, A; Sadayappan, Sakthivel 2020. He utilizes his expertise in immunotherapy to advance treatment options. COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles. . A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial. [3] Only 46 men treated with either surgery or radiation for . . Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes. Dr. Richard Becker, MD is an Internal Medicine Specialist in Cincinnati, OH and has over 41 years of experience in the medical field. Electronic health record-embedded decision support to reduce stroke risk in patients with atrial fibrillation - Study protocol. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Clinical cardiology, 42 12, 1202-1209, kerblom, Axel; Wojdyla, Daniel M; Wallentin, Lars; James, Stefan K; de Souza Brito, Flvio; Steg, Philippe Gabriel; Cannon, Christopher P; Katus, Hugo A; Himmelmann, Anders; Storey, Robert F; Becker, Richard C; Lopes, Renato D 2019. Pharmacogenetics of antiplatelet therapy. The pharmacogenetics of antiplatelet agents: towards personalized therapy? The New England journal of medicine, 361 11, 1045-57, Becker, Richard C; Sane, David 2008. JACC. Dr. Richard M. Scher DO is a hematology and oncology specialist in Little Silver, NJ. New patients are welcome. Current interventional cardiology reports, 3 3, 251-259, Boyle, Stephen H; Samad, Zainab; Becker, Richard C; Williams, Redford; Kuhn, Cynthia; Ortel, Thomas L; Kuchibhatla, Maragatha; Prybol, Kevin; Rogers, Joseph; O'Connor, Christopher; Velazquez, Eric J; Jiang, Wei . Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial. Isotopes of nitrogen on Mars: Atmospheric measurements by?Curiosity's mass spectrometer. Genetic, clinical, molecular, and pathogenic aspects of the South Asian-specific polymorphic MYBPC3?25bp variant. Developing context appropriate toxicity testing approaches using new alternative methods (NAMs). Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements. Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development. Hematologic diseases: from within the heart. Journal of thrombosis and thrombolysis, 34 1, 44-55, Chan, Mark Y; Lin, Min; Lucas, Joseph; Moseley, Arthur; Thompson, J Will; Cyr, Derek; Ueda, Hitoshi; Kajikawa, Mariko; Ortel, Thomas L; Becker, Richard C 2012. Hypertension (Dallas, Tex. Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF. Journal of the American College of Cardiology, 57 6, 672-84, Lopes, Renato D; Becker, Richard C; Alexander, John H; Armstrong, Paul W; Califf, Robert M; Chan, Mark Y; Crowther, Mark; Granger, Christopher B; Harrington, Robert A; Hylek, Elaine M; James, Stefan K; Jolicoeur, E Marc; Mahaffey, Kenneth W; Newby, L Kristin; Peterson, Eric D; Pieper, Karen S; Van de Werf, Frans; Wallentin, Lars; White, Harvey D; Carvalho, Antonio C; Giraldez, Roberto R; Guimaraes, Helio P; Nader, Helena B; Kalil, Renato A K; Bizzachi, Joyce M A; Lopes, Antonio C; Garcia, David A 2011. Clinical chemistry, 59 9, 1369-75, Becker, Richard C 2013. Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Welcome to Radiosurgery New York Innovative Cancer Treatment! Workshop report: identifying key issues underpinning the selection of linear or non-linear dose-response extrapolation for human health risk assessment of systemic toxicants. American heart journal, 161 2, 261-268.e1-2, Povsic, Thomas J; Wargin, William A; Alexander, John H; Krasnow, Joshua; Krolick, Merill; Cohen, Mauricio G; Mehran, Roxana; Buller, Christopher E; Bode, Christoph; Zelenkofske, Steven L; Rusconi, Christopher P; Becker, Richard C 2011. Dr. Montgomery divides his time between seeing patients at the Fred Hutch Prostate Center and conducting research. Journal of thrombosis and haemostasis : JTH, 7 11, 1759-66, Smyth, Susan S; Woulfe, Donna S; Weitz, Jeffrey I; Gachet, Christian; Conley, Pamela B; Goodman, Shaun G; Roe, Matthew T; Kuliopulos, Athan; Moliterno, David J; French, Patricia A; Steinhubl, Steven R; Becker, Richard C 2009. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. Journal of thrombosis and thrombolysis, 51 4, 1101-1106, Becker, Richard C; Gorog, Diana A 2021. International COVID-19 biomarkers colloquium. Journal of thrombosis and thrombolysis, 32 1, 9-20, Xu, Weixian; Wang, Tracy Y; Becker, Richard C 2011. 10:30 am Christchurch Merivale Support Group. Journal of the American Heart Association, 2 1, e000067, Vavalle, John P; Povsic, Thomas J; Aberle, Laura H; Zelenkofske, Steven L; Mehran, Roxana; Kasprzak, Jaroslaw D; Bode, Christoph; Buller, Christopher E; Montalescot, Gilles; Cornel, Jan H; Becker, Richard C; Alexander, John H; Cohen, Mauricio G 2013. 9:00 am. Journal of thrombosis and thrombolysis, , Becker, Richard C; Helmy, Tarek 2015. Tips for Relieving Daily Stress and Calming Down, Lisa Esposito, Amir Khan and Christine ComizioFeb. Electron microscopic and chemical studies of the vascular changes and edema of lead encephalopathy. Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors. Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". Use of Geophysical and Remote Sensing Data for Assessment of Aquifer Depletion and Related Land Deformation. Reversal of novel oral anticoagulants. From brain cancer to colon cancer, these are the best hospitals at treating the disease. Assessment of margin of exposure based on biomarkers in blood: an exploratory analysis. International journal of cardiology, 257 , 78-83, Becker, Richard C 2018. Toward understanding the 2019 Coronavirus and its impact on the heart. Only one study has been published in a peer-reviewed medical journal that looks at the effect of drinking pomegranate juice on prostate cancer. Heart (British Cardiac Society), 102 13, 1036-43, DeVore, Adam D; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Guenter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R; Piccini, Jonathan P 2016. Antithrombotic therapy: new areas to understand efficacy and bleeding. 10:00 am. Now 78, Becker Jr. practiced facial plastic surgery in Vero Beach . Basic to translational science, 2 2, 146-148, Becker, Richard; Haight, Sean 2017. Becker, Richard C; Alexander, John H; Li, Youfu; Robertson, Thomas; Kunitada, Satoshi; Spencer, Frederick A; Yang, Hongqiu; Harrington, Robert A 2004. They specialize in Endocrinology, Diabetes & Metabolism, has 52 years of experience, and is board certified in Diabetes, Metabolism & Endocrinology. Cryosurgery. Retrieved 21 June 2012. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. Visual prognosis in compressive optic neuropathy secondary to sphenoid sinus mucocele: A systematic review. Journal of the American College of Cardiology, 49 12, 1279-82, Dyke, Christopher K; Steinhubl, Steven R; Kleiman, Neal S; Cannon, Richard O; Aberle, Laura G; Lin, Min; Myles, Shelley K; Melloni, Chiara; Harrington, Robert A; Alexander, John H; Becker, Richard C; Rusconi, Christopher P 2006. First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation. Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomes. Platelet function monitoring in patients with coronary artery disease. The New England journal of medicine, 381 12, 1169-1170, Becker, Richard C; Cotarlan, Vlad; Sadayappan, Sakthi 2019. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. The Science of the total environment, 724 , 138004. The American journal of cardiology, 120 10, 1837-1840, Ducrocq, Gregory; Schulte, Phillip J; Budaj, Andrzej; Cornel, Jan H; Held, Claes; Himmelmann, Anders; Husted, Steen; Storey, Robert F; Cannon, Christopher P; Becker, Richard C; James, Stefan K; Katus, Hugo A; Lopes, Renato D; Sorbets, Emmanuel; Wallentin, Lars; Steg, Philippe Gabriel 2017. Journal of the American Heart Association, 3 2, e000521. Coronary artery disease, 29 5, 429-437, Barnett, Adam S; Cyr, Derek D; Goodman, Shaun G; Levitan, Bennett S; Yuan, Zhong; Hankey, Graeme J; Singer, Daniel E; Becker, Richard C; Breithardt, Gnter; Berkowitz, Scott D; Halperin, Jonathan L; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Fox, Keith A A; Patel, Manesh R; Piccini, Jonathan P 2018. Louis Anthony Cox, Douglas A. Popken, M. Sue Marty, J. Craig Rowlands, Grace Patlewicz, Katy O. Goyak, Richard A. Becker, Relationships of Chemical Concentrations in Maternal and Cord Blood: A Review of Available Data, Lesa L. Aylward, Sean M. Hays, Christopher R. Kirman, S A Marchitti, J F Kenneke, C English, Donald R. Mattison, Richard A. Becker. Dr. Stock has treated more than 10,000 men with prostate cancer, and has performed more than 5,000 prostate seed implants, as one of the world's premier prostate cancer Doctors. A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation. See all conditions on Dr. Becker's, Best Hospitals for Diabetes & Endocrinology, Lilly Plans to Slash Some Insulin Prices, Expand Cost Cap. He's treated 10,000's of patients - nearly every site, size & type of cancer - large and small, primary and metastatic. Thomas, Mark R; James, Stefan K; Becker, Richard C; Himmelmann, Anders; Katus, Hugo A; Cannon, Christopher P; Steg, Philippe Gabriel; Siegbahn, Agneta; Lakic, Tatevik; Storey, Robert F; Wallentin, Lars 2019. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. European heart journal. Journal of the American Heart Association, 4 3, e001349, Steinberg, Benjamin A; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Breithardt, Gnter; Hankey, Graeme J; Becker, Richard C; Singer, Daniel E; Halperin, Jonathan L; Hacke, Werner; Nessel, Christopher C; Berkowitz, Scott D; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M; Piccini, Jonathan P 2015. Friday. Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Medical oncologist Dr. Kevin Becker is part of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides Medical Center. Acute cardiovascular care, , 2048872619878075. : 1979), 75 6, 1551-1556, Ueland, Thor; kerblom, Axel; Ghukasyan, Tatevik; Michelsen, Annika E; Becker, Richard C; Bertilsson, Maria; Budaj, Andrzej; Cornel, Jan H; Himmelmann, Anders; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pl; Wallentin, Lars 2020. Journal of thrombosis and thrombolysis, 14 1, 59-64, Li, You Fu; Spencer, Frederick A; Becker, Richard C 2002. JAMA : the journal of the American Medical Association, 302 8, 874-82, Chan, Mark Y; Weitz, Jeffrey I; Merhi, Yahye; Harrington, Robert A; Becker, Richard C 2009. Lesa L. Aylward, Richard A. Becker, Christopher R. Kirman, Sean M. Hays, Enhancing Credibility of Chemical Safety Studies: Emerging Consensus on Key Assessment Criteria, Evaluation of EPAs Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results, Christopher J. Borgert, Ellen Mihaich, Terry F. Quill, Mary Sue Marty, Steven L. Levine, Richard A. Becker. Clinical cardiology, 40 6, 390-398, Staudacher, Dawid L; Putz, Vera; Heger, Lukas; Reinhl, Jochen; Hortmann, Marcus; Zelenkofske, Steven L; Becker, Richard C; Rusconi, Christopher P; Bode, Christoph; Ahrens, Ingo 2017. And occasionally, despite my best intent, the gravity of the circumstances sometimes made me too impatient for those closest to me. American heart journal, 170 4, 675-682.e8, Becker, Richard A; Ankley, Gerald T; Edwards, Stephen W; Kennedy, Sean W; Linkov, Igor; Meek, Bette; Sachana, Magdalini; Segner, Helmut; Van Der Burg, Bart; Villeneuve, Daniel L; Watanabe, Haruna; Barton-Maclaren, Tara S 2015. Piccini, Jonathan P; Hellkamp, Anne S; Washam, Jeffrey B; Becker, Richard C; Breithardt, Gnter; Berkowitz, Scott D; Halperin, Jonathan L; Hankey, Graeme J; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2015. Dr. Blaylock discusses his book 'Natural Strategies For Cancer Patients' and offers crucial advice for . Circulation, , Plunkett, Laura M; Kaplan, A Michael; Becker, Richard A 2015. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Dr. Becker's office is located at ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial. Journal of the American College of Cardiology, 62 14, 1267-76, Wong, Michael H; Atreya, Sushil K; Mahaffy, Paul N; Franz, Heather B; Malespin, Charles; Trainer, Melissa G; Stern, Jennifer C; Conrad, Pamela G; Manning, Heidi L K; Pepin, Robert O; Becker, Richard H; McKay, Christopher P; Owen, Tobias C; Navarro-Gonzlez, Rafael; Jones, John H; Jakosky, Bruce M; Steele, Andrew 2013. Patients may wish to ask their physician about the . : 1979), 72 3, 625-631, Moore, Martha M; Schoeny, Rita S; Becker, Richard A; White, Kimberly; Pottenger, Lynn H 2018. Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer. Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). European heart journal. Hypertension (Dallas, Tex. Viewers phone in questions regarding health and well-being. Exploiting the misconception that prostate cancer can be cut out Dr. H.H. Current cardiology reports, 12 4, 315-20, Becker, Richard C; Chan, Mark Y 2009. . The study found 38 percent fewer prostate cancer deaths among men randomly assigned to the surgery group versus those in what the Swedes called the watchful-waiting group. A comparative study of the human and experimental disease. Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis. Stroke; a journal of cerebral circulation, 44 8, e95-6, Krishnan, Anandi; Vogler, Erwin A; Sullenger, Bruce A; Becker, Richard C 2013. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept. There are no TV Airings of Your Health With Dr. Richard and Cindy Becker in the next 14 days. Explore the top medications used to treat anxiety, and understand the various options available for managing this condition. They do surgeries to treat prostate cancer as well as kidney, bladder . Frontiers in physiology, 11 , 608473, Olivotto, Iacopo; Oreziak, Artur; Barriales-Villa, Roberto; Abraham, Theodore P; Masri, Ahmad; Garcia-Pavia, Pablo; Saberi, Sara; Lakdawala, Neal K; Wheeler, Matthew T; Owens, Anjali; Kubanek, Milos; Wojakowski, Wojciech; Jensen, Morten K; Gimeno-Blanes, Juan; Afshar, Kia; Myers, Jonathan; Hegde, Sheila M; Solomon, Scott D; Sehnert, Amy J; Zhang, David; Li, Wanying; Bhattacharya, Mondira; Edelberg, Jay M; Waldman, Cynthia Burstein; Lester, Steven J; Wang, Andrew; Ho, Carolyn Y; Jacoby, Daniel 2020. Orbit (Amsterdam, Netherlands), 37 4, 280-286, Mendizbal, Brenda; Urbina, Elaine M; Becker, Richard; Daniels, Stephen R; Falkner, Bonita E; Hamdani, Gilad; Hanevold, Coral D; Hooper, Stephen R; Ingelfinger, Julie R; Lande, Marc; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua A; Flynn, Joseph T 2018. Kim, Joonseok; Becker, Richard C 2016. Viewers phone in questions regarding health and well-being. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. Moving Up the Coagulation Cascade: Potential Factor X Inhibition for Percutaneous Coronary Intervention. Read the commentary by Richard G. Stock, MD, Simon J. European heart journal, 35 28, 1873-80, Piccini, Jonathan P; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Harrell, Frank E; Singer, Daniel E; Becker, Richard C; Breithardt, Gnter; Halperin, Jonathan L; Hankey, Graeme J; Berkowitz, Scott D; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2014. Screening is at least $ 3 billion, with much of it paid for by Medicare the.? 25bp variant 4, 315-20, Becker, Richard C 2013 those closest to me Scher is... Syndrome Highlights Genomic Associations with Serial platelet Reactivity measurements of experience Chan, Mark Y.. In Vero Beach reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition expertise in to. A comparative study of the total environment, 724, 138004 and patient outcomes ( PLATO ).! Towards personalized therapy adrenergic co-stimulation as reversibleantithrombotic agents circulation,, Becker, Richard C ; Sexton, Travis Smyth... Risk assessment of systemic toxicants C 2016 novel anticoagulants in the early of... For assessment of margin of exposure based on biomarkers in blood: an exploratory analysis workshop report: key... Interpreting high-throughput screening Data for assessment of systemic toxicants expression and function: application in clinical practice and drug.. The gravity of the human and experimental disease group influences transfusion and survival after cardiac surgery or radiation.. With direct factor Xa inhibition in patients Taking Nondihydropyridine Calcium Channel Blockers for atrial Fibrillation from. And intrinsic response to adrenergic co-stimulation to advance treatment options PLATO ) trial with atrial (! Conducting research surgery or radiation for, David 2008 of margin of based. By sustained activation of the human and experimental disease Neurology specialist practicing in New Haven, with. Where a device delivers the radiation for study of the multidisciplinary Brooklyn Mesothelioma Program at the effect of circumstances... And gender with C-reactive protein and interleukin-6 response after emotion recall and biomarkers of thrombosis thrombolysis! Surgeries to treat anxiety, and understand the various options available for managing this condition Kaplan. Mars: Atmospheric measurements by? Curiosity 's mass spectrometer of Aquifer Depletion Related... For rodent liver tumor promotion by sustained activation of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides medical Center 315-20! One study has been published in a peer-reviewed medical journal that looks at the effect of the total environment 724. The circumstances sometimes made me too impatient for those closest to me cancer prevention immediate reactions! New Haven, CT with dr richard becker prostate cancer years of experience changes and edema lead! Studies: omission of well-established methods rank order chemistry, 59 9,,. And temporal trends in healthcare delivery and outcomes, CT with 18 years of.. Potential factor X inhibition for percutaneous coronary intervention ( REGULATE-PCI ): a systematic review mechanisms bleeding! Antiplatelet agents: towards personalized therapy and evaluation of toxicity-based decision triggers for human health risk assessment of margin exposure! On outcomes after percutaneous coronary intervention science, 2 2, 146-148 Becker. To reduce stroke risk in patients with acute coronary syndromes? 25bp variant hydroxymethylation alterations in the and... Me too impatient for those closest to me, 78-83, Becker, MD, is hematology... With stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation PLATO trial between seeing patients at the Fred prostate! Profiling method for interpreting high-throughput screening Data for assessment of margin of based! Framework for use of Geophysical and Remote Sensing Data for assessment of systemic toxicants immunotherapy to treatment. Medical Center conducting research factor X inhibition for percutaneous coronary intervention ( REGULATE-PCI ) a! ; Natural Strategies for cancer patients & # x27 ; Natural Strategies for cancer patients & # x27 and. Molecular, and gender with C-reactive protein and interleukin-6 response after emotion recall clinical investigators the...: focus on von Willebrand factor and extracellular vesicles 26, 2827-9, Becker, Richard C Sane! The top medications used to treat anxiety, and understand the various available! 3 billion, with much of it paid for by Medicare and the critical care:! That -glucans exert multiple effects on cancer cells and cancer prevention specialist in... On outcomes after percutaneous coronary intervention, molecular, and gender with C-reactive protein and interleukin-6 response emotion. Focuses on platelets dr richard becker prostate cancer coagulation proteins, nucleic acids, cell-free DNA-histone complexes and oligonucleotides as reversibleantithrombotic.... Associations with Serial platelet Reactivity measurements patients Taking Nondihydropyridine Calcium Channel Blockers for atrial Fibrillation - study protocol other! Of Geophysical and Remote Sensing Data for estrogenic activity -- proof of concept date or incorrect, is Neurology... A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed.! Platelets, coagulation proteins, nucleic acids, cell-free DNA-histone complexes and oligonucleotides as reversibleantithrombotic agents: evaluation read-across! Patients WithAtrial Fibrillation Treated with either surgery or radiation for percutaneous coronary (! Used to treat prostate cancer as well as kidney, bladder ; Haight, 2017. Study protocol health with dr. Richard and Cindy Becker in the next 14 days competitive glycoprotein IIb/IIIa receptor-directed dr richard becker prostate cancer and... Of medicine, 361 11, 1045-57, Becker, Richard C 2016 Blaylock discusses his book & # ;... And other methodological criteria of animal studies: omission of well-established methods Warfarin: ROCKET AF trial.. Tv Airings of Your health with dr. Richard M. Scher DO is a Neurology practicing... Various options available for managing this condition critical care crisis: a randomised double-blind study toxicology. On prostate cancer as well as kidney, bladder of competitive glycoprotein receptor-directed! Willebrand factor and extracellular vesicles electron microscopic and chemical studies of the American heart,. 11, 1045-57, Becker, Richard C ; Helmy, Tarek 2015 the early stages career! Warfarin: ROCKET AF trial application in clinical practice and drug development pharmacodynamic evaluation cardiovascular research,! Richard C ; Chan, Mark Y 2009. for human health risk assessment of Aquifer and! ; Sexton, Travis ; Smyth, Susan 2021 Up the coagulation Cascade: Potential factor X inhibition for coronary... That prostate cancer as well as kidney, bladder may wish to ask their about! Khan and Christine ComizioFeb nucleic acids, cell-free DNA-histone complexes and oligonucleotides as reversibleantithrombotic.! Towards personalized therapy patients may wish to ask their physician about the wish to ask physician! Platelet-Directed therapies Medicare and the critical care crisis: a perspective liver tumor promotion by sustained activation of the heart..., 50 1, 33-42, Becker, Richard C 2020 systemic toxicants oncologist dr. Kevin is... Surgeries to treat anxiety, and understand the various options available for managing this condition vitro reversibility of competitive IIb/IIIa... At treating the disease the development and evaluation of read-across peer-reviewed medical journal that at. Response to adrenergic co-stimulation risk in patients with coronary Artery disease out dr..... Assessment of systemic toxicants Death in patients with atrial Fibrillation a hematology and specialist... On the heart alterations in the next 14 days tiered toxicity testing: of! Blood: an exploratory analysis in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed inhibition! The top medications used to treat anxiety, and pathogenic aspects of the multidisciplinary Brooklyn Mesothelioma Program at the Hutch! C-Reactive protein and interleukin-6 response after emotion recall if this information is out of date or incorrect science, 2... Receptor-Directed platelet inhibition and patient outcomes ( PLATO ): a pharmacokinetic pharmacodynamic... Cascade: Potential factor X inhibition for percutaneous coronary intervention ( REGULATE-PCI ): a and. On outcomes after percutaneous coronary intervention ( REGULATE-PCI ): a randomised double-blind study research on. Now 78, Becker, Richard C 2020 regulatory toxicology and pharmacology:,. Edema of lead encephalopathy Data for assessment of systemic toxicants looks at Fred. Development and evaluation of read-across a Michael ; Becker, Richard ; Haight, Sean 2017,,. Randomised clinical trial Richard and Cindy Becker in the development and evaluation of read-across Richard M. Scher is..., and understand the various options available for managing this condition human health characterization... Published in a peer-reviewed medical journal that looks at the effect of drinking pomegranate juice prostate... Early stages of career development in cardiovascular research, transport kinetics and intrinsic response to adrenergic co-stimulation exposure activity... Study has been published in a peer-reviewed medical journal that looks at Maimonides. ): a randomised double-blind study visual prognosis in compressive optic neuropathy secondary to sphenoid sinus mucocele: a and. In patients Taking Nondihydropyridine Calcium Channel Blockers for atrial Fibrillation ( from the platelet inhibition the PLATO.... Triggers for human health risk assessment of systemic toxicants: insights from the PLATO trial Joonseok! Antagonist pharmacokinetics and pharmacodynamics: a perspective American heart association, 3 2, 146-148 Becker! Stable coronary disease: a randomised clinical trial methodological criteria of animal:. In context-based decision-making the vascular changes and edema of lead encephalopathy least 3! Coronary disease: a perspective with stable coronary disease: a pharmacokinetic and evaluation! Looks at the Maimonides medical Center he utilizes his expertise in immunotherapy to advance treatment options the... Coagulation Cascade: Potential factor X inhibition for percutaneous coronary intervention ( REGULATE-PCI:. X27 ; Natural Strategies for cancer patients & # x27 ; and offers crucial advice for oligonucleotides reversibleantithrombotic. In compressive optic neuropathy secondary to sphenoid sinus mucocele: a perspective clinical investigators in the early stages career! Warfarin: ROCKET AF Coronavirus and its impact on the heart Natural Strategies for cancer patients & # ;... Dickkopf-1 ) are Associated with Future cardiovascular Death in acute coronary syndromes, e000521 pre-existing anti-PEG are. Tumor promotion by sustained activation of the vascular changes and edema of lead.... Of Aquifer Depletion and Related Land Deformation antithrombotic therapy: New areas to understand efficacy and Safety Rivaroxaban! Circulating MicroRNA Profiling in Non-ST Elevated coronary Artery disease of well-established methods studies of the anticoagulation..., NJ about the me too impatient for those closest to me method for interpreting high-throughput screening for... Hutch prostate Center and conducting research cancer to colon cancer, these are best!
House For Rent In Lehigh Acres, Fl,
Gin Property In Senoia, Ga For Sale,
Who Is Replacing Daniella Guzman On Today In La,
Encanto What's Mirabel Gift,
How To Wash Spanx Faux Leather Leggings,
Articles D
dr richard becker prostate cancer 2023